VIVO Meridian Bioscience, Inc. Stock Quote

VIVO [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	20.00	EPS (ttm)	1.07	Insider Own	1.10%	Shs Outstand	42.96M	Perf Week	-6.32%
Market Cap	906.30M	Forward P/E	19.96	EPS next Y	1.07	Insider Trans	1.08%	Shs Float	42.82M	Perf Month	2.15%
Income	46.20M	PEG	1.18	EPS next Q	0.42	Inst Own	94.30%	Short Float	8.86%	Perf Quarter	12.01%
Sales	253.70M	P/S	3.57	EPS this Y	88.20%	Inst Trans	2.29%	Short Ratio	6.89	Perf Half Y	-9.11%
Book/sh	5.76	P/B	3.71	EPS next Y	-13.92%	ROA	12.50%	Target Price	26.67	Perf Year	107.58%
Cash/sh	1.26	P/C	16.94	EPS next 5Y	17.00%	ROE	20.90%	52W Range	5.51 - 26.58	Perf YTD	14.29%
Dividend	-	P/FCF	20.28	EPS past 5Y	4.80%	ROI	15.20%	52W High	-19.64%	Beta	0.59
Dividend %	-	Quick Ratio	1.90	Sales past 5Y	5.40%	Gross Margin	61.60%	52W Low	287.66%	ATR	1.13
Employees	560	Current Ratio	3.10	Sales Q/Q	26.40%	Oper. Margin	24.20%	RSI (14)	50.29	Volatility	4.82% 5.27%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	55.70%	Profit Margin	18.20%	Rel Volume	0.76	Prev Close	22.21
Shortable	Yes	LT Debt/Eq	0.28	Earnings	Feb 05 BMO	Payout	0.00%	Avg Volume	550.57K	Price	21.36
Recom	1.50	SMA20	-0.20%	SMA50	6.96%	SMA200	17.31%	Volume	420,587	Change	-3.83%

Aug-11-20

Resumed

Piper Sandler

Overweight

$24

Jul-27-20

Initiated

H.C. Wainwright

Buy

$34

May-11-20

Upgrade

William Blair

Mkt Perform → Outperform

May-01-19

Upgrade

Piper Jaffray

Underweight → Neutral

$15 → $11

Apr-03-19

Downgrade

Canaccord Genuity

Hold → Sell

$17 → $11

Jan-26-18

Reiterated

Canaccord Genuity

Hold

$14 → $16

Mar-28-17

Initiated

CL King

Neutral

Mar-28-16

Reiterated

Canaccord Genuity

Hold

$18 → $19

Sep-10-15

Reiterated

Canaccord Genuity

Hold

$19 → $18

Jul-27-15

Reiterated

Canaccord Genuity

Hold

$20 → $19

May-04-15

Reiterated

Canaccord Genuity

Hold

$19 → $20

Nov-06-14

Downgrade

Robert W. Baird

Outperform → Neutral

$22 → $22

Jul-27-12

Downgrade

Canaccord Genuity

Buy → Hold

Apr-25-11

Upgrade

Wedbush

Underperform → Neutral

$18 → $22

Mar-24-11

Upgrade

Canaccord Genuity

Hold → Buy

$30

Nov-16-10

Initiated

Canaccord Genuity

Hold

$21

Apr-07-10

Initiated

Wedbush

Underperform

$18

Nov-13-09

Reiterated

Caris & Company

Average

$21 → $20

Jul-07-09

Initiated

Caris & Company

Average

$21

Mar-06-09

Initiated

William Blair

Mkt Perform

Jan-27-21 10:42AM	Abbott (ABT) Q4 Earnings Top, Diagnostic Test Sales Solid Zacks
Jan-21-21 05:50PM	Meridian Bioscience (VIVO) Stock Sinks As Market Gains: What You Should Know Zacks
Jan-20-21 12:10PM	Why the Earnings Surprise Streak Could Continue for Meridian Bioscience (VIVO) Zacks
Jan-19-21 09:56AM	Insulet (PODD) Omnipod DASH Reaches Canada, Global Hold Widens Zacks +5.79%
Jan-14-21 05:50PM	Meridian Bioscience (VIVO) Gains As Market Dips: What You Should Know Zacks
Jan-13-21 04:30PM	Meridian Bioscience to Hold First Quarter Fiscal 2021 Financial Results Conference Call on February 5, 2021 GlobeNewswire
Jan-12-21 08:03AM	Meridian Bioscience, Inc. (NASDAQ:VIVO) Insiders Increased Their Holdings Simply Wall St.
Jan-11-21 07:09AM	Zacks.com featured highlights include: Vista Outdoor, Meridian Bioscience, Owens & Minor and Lakeland Industries Zacks
Jan-08-21 11:12AM	Meridian Bioscience, PayPal, Microsoft and JPMorgan highlighted as Zacks Bull and Bear of the Day Zacks
09:12AM	Buy These 5 Low-Beta Stocks to Combat the Choppy Market Zacks
06:48AM	The Zacks Analyst Blog Highlights: Ryerson Holding, Schnitzer Steel, Scholastic, P.A.M. Transportation Services and Meridian Bioscience Zacks
05:54AM	Zacks.com featured highlights include: Bonanza Creek Energy, Meridian Bioscience, Ameris and Lakeland Industries Zacks
05:20AM	Bull of the Day: Meridian Bioscience (VIVO) Zacks
Jan-07-21 08:19AM	Zacks.com featured highlights include: Bellicum Pharmaceuticals, Prometic Life Sciences, Vaccinex, Meridian Bioscience and 360 DigiTech Zacks
08:00AM	Meridian Bioscience Announces Better-than-expected Preliminary First Quarter Fiscal 2021 Revenue Results GlobeNewswire
Jan-06-21 09:30AM	Meridian Bioscience to Participate in H. C. Wainright Bioconnect 2021 Virtual Conference GlobeNewswire +5.07%
Jan-05-21 12:20PM	Can Meridian Bioscience (VIVO) Run Higher on Rising Earnings Estimates? Zacks
Dec-31-20 11:30AM	Is Meridian Bioscience (VIVO) Outperforming Other Medical Stocks This Year? Zacks
Dec-29-20 03:31PM	Top Stock Picks for Week of December 28, 2020 Zacks -5.41%
06:55AM	These 3 Stocks Could Turn Your $600 Stimulus Check Into Much More Motley Fool
Dec-28-20 07:59AM	6 Top-Rated Stocks With Solid Net Profit Margin Zacks
Dec-18-20 01:12AM	Is VIVO A Good Stock To Buy Now? Insider Monkey
Dec-17-20 10:28AM	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Meridian Bioscience, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors PR Newswire
Dec-16-20 03:00PM	Meridian Bioscience receives NIH Award for supporting rapid development of Revogene® molecular test for SARS-CoV-2 GlobeNewswire
Dec-14-20 10:34AM	Zacks.com featured highlights include: Meridian Bioscience, Piper Sandler, Herc Holdings, Aviat Networks and Carriage Services Zacks
07:19AM	A Look At The Intrinsic Value Of Meridian Bioscience, Inc. (NASDAQ:VIVO) Simply Wall St.
Dec-11-20 07:58AM	6 Top-Rated Stocks to Bet On With Solid Net Profit Margins Zacks
Dec-09-20 11:30AM	Is Meridian Bioscience (VIVO) Stock Outpacing Its Medical Peers This Year? Zacks
Dec-08-20 10:17AM	Meridian Bioscience submits application to FDA for Emergency Use Authorization for SARS-CoV-2 molecular assay GlobeNewswire
Dec-03-20 12:20PM	Why Meridian Bioscience (VIVO) Might be Well Poised for a Surge Zacks
10:00AM	Meridian Launches its Novel Air-Dryable RT-qPCR Mix, Further Decreases Costs and Simplifies Workflows for COVID-19 Molecular Test Manufacturers GlobeNewswire
Nov-23-20 10:00AM	Meridian Bioscience Participates in Piper Sandler 32nd Annual Virtual Healthcare Conference GlobeNewswire -7.42%
Nov-20-20 08:35AM	Zacks.com featured highlights include: Vista Outdoor, Meridian Bioscience, Standard Motor Products, NIC and Azure Power Zacks
Nov-18-20 11:25AM	New Strong Buy Stocks For November 18th Zacks
Nov-17-20 11:30AM	Has Meridian Bioscience (VIVO) Outpaced Other Medical Stocks This Year? Zacks
Nov-16-20 12:00PM	Meridian Bioscience to Participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum GlobeNewswire +6.68%
05:55AM	Should Weakness in Meridian Bioscience, Inc.'s (NASDAQ:VIVO) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? Simply Wall St.
Nov-13-20 01:30PM	Meridian Bioscience Inc (VIVO) Q4 2020 Earnings Call Transcript Motley Fool
10:10AM	Meridian Bioscience (VIVO) Q4 Earnings and Revenues Top Estimates Zacks
07:30AM	Meridian Bioscience Reports Strong Fourth Quarter and Record Full-Year Fiscal 2020 Operating Results and Provides Fiscal 2021 Guidance GlobeNewswire
Nov-06-20 12:30PM	Meridian Bioscience (VIVO) Earnings Expected to Grow: Should You Buy? Zacks
Oct-26-20 01:50PM	Dow Jones Plunges As Pelosi-Mnuchin Stimulus Talks Continue; These Breakouts Struggle Investor's Business Daily
Oct-21-20 01:44PM	Do Meridian Bioscience's (NASDAQ:VIVO) Earnings Warrant Your Attention? Simply Wall St.
Oct-20-20 11:00AM	Meridian Bioscience to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call on November 13, 2020 GlobeNewswire
Oct-16-20 01:38PM	Dow Jones Leads As Stock Market Rallies On Retail Sales, Coronavirus News Investor's Business Daily -7.40%
Oct-07-20 09:00AM	Meridian Bioscience Launches a Complete Solution to Support Liquid Biopsy Cancer Diagnostics GlobeNewswire
Oct-06-20 10:23PM	Hedge Funds Are Crazy About Meridian Bioscience, Inc. (VIVO) Insider Monkey
Sep-17-20 03:17PM	The Meridian Bioscience (NASDAQ:VIVO) Share Price Has Gained 62% And Shareholders Are Hoping For More Simply Wall St.
Sep-14-20 10:00AM	Meridian launches a novel SARS-CoV-2 antibody pair designed for developing highly sensitive rapid antigen tests from saliva samples GlobeNewswire
Aug-31-20 08:00AM	Meridian Bioscience to Present at the H. C. Wainright 22nd Annual Global Investment Conference GlobeNewswire
Aug-25-20 09:31AM	There's No Escaping Meridian Bioscience, Inc.'s (NASDAQ:VIVO) Muted Earnings Simply Wall St.
Aug-07-20 09:05AM	Meridian Bioscience (VIVO) Beats Q3 Earnings and Revenue Estimates Zacks -20.46%
08:52AM	Are Institutions Heavily Invested In Meridian Bioscience, Inc.'s (NASDAQ:VIVO) Shares? Simply Wall St.
07:30AM	Meridian Bioscience Reports Fiscal Third Quarter 2020 Operating Results Best Quarter in Company History Raises Full Year Guidance GlobeNewswire
Aug-06-20 04:00PM	Earnings Outlook for Meridian Bioscience Benzinga -8.03%
Aug-05-20 09:42AM	What's in Store for Meridian Bioscience's (VIVO) Q3 Earnings? Zacks
Jul-31-20 05:45PM	Meridian Bioscience (VIVO) Stock Sinks As Market Gains: What You Should Know Zacks
12:30PM	Meridian Bioscience (VIVO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Jul-28-20 10:24AM	Did Hedge Funds Make The Right Call On Meridian Bioscience, Inc. (VIVO) ? Insider Monkey
09:00AM	Meridian Bioscience Announces New Board Member - Anthony Bihl GlobeNewswire
Jul-27-20 09:33AM	Benzinga's Top Upgrades, Downgrades For July 27, 2020 Benzinga +6.74%
Jul-16-20 09:00AM	Meridian Bioscience to Hold Third Quarter 2020 Financial Results Conference Call on August 7, 2020 GlobeNewswire
Jul-13-20 01:57PM	Is Meridian Bioscience (NASDAQ:VIVO) Using Too Much Debt? Simply Wall St.
01:00PM	Meridian Bioscience Announces the Launch of a High-Sensitivity SARS-CoV-2 Nucleocapsid Antibody Pair for the Development of Rapid COVID-19 Antigen Assays GlobeNewswire
Jul-10-20 11:30AM	Is Meridian Bioscience (VIVO) Stock Outpacing Its Medical Peers This Year? Zacks
Jul-01-20 09:37AM	The Zacks Analyst Blog Highlights: Galiano Gold, Fortinet, Meridian Bioscience, Crescent Capital BDC and NextEra Energy Zacks
Jun-30-20 09:56AM	Zacks.com featured highlights include: eXp World, Lakeland Industries, Meridian Bioscience, Kiniksa Pharmaceuticals and iClick Interactive Asia Group Zacks +6.93%
Jun-29-20 08:09AM	5 Stocks With Recent Price Strength Amid Spike in Coronavirus Zacks
Jun-24-20 11:18AM	New Strong Buy Stocks for June 24th Zacks
Jun-22-20 11:59AM	Hedge Funds Have Never Been This Bullish On Meridian Bioscience, Inc. (VIVO) Insider Monkey
Jun-18-20 09:15AM	Meridian Bioscience (VIVO) Soars to 52-Week High, Time to Cash Out? Zacks
Jun-15-20 03:51PM	Edited Transcript of VIVO.OQ earnings conference call or presentation 8-May-20 2:00pm GMT Thomson Reuters StreetEvents
May-29-20 08:00AM	Meridian Bioscience to Participate in the 40th Annual William Blair Growth Stock Conference GlobeNewswire +9.03%
May-26-20 08:00AM	Meridian Bioscience Announces It Will Supply Reagents for the Manufacturing of Tens of Millions of COVID-19 Antibody Tests Per Month GlobeNewswire
May-20-20 04:20PM	Meridian Bioscience Promotes Tony Serafini-Lamanna to Executive Vice President of Diagnostics GlobeNewswire
May-12-20 04:20PM	Top Stock Picks for Week of May 11, 2020 Zacks
May-09-20 08:01PM	Meridian Bioscience Inc (VIVO) Q2 2020 Earnings Call Transcript Motley Fool
May-08-20 08:55AM	Meridian Bioscience (VIVO) Q2 Earnings and Revenues Surpass Estimates Zacks +6.97%
08:02AM	Recap: Meridian Bioscience Q2 Earnings Benzinga
07:30AM	Meridian Bioscience Reports Second Quarter 2020 Operating Results; Raises Guidance on Strength of COVID-19 Related Products GlobeNewswire
May-06-20 05:51PM	Why Meridian Bioscience Stock Shot Up Nearly 13% Today Motley Fool +12.83%
08:00AM	Meridian Bioscience Partners with QuantuMDx on COVID-19 Assay GlobeNewswire
May-01-20 12:30PM	Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-30-20 10:51AM	Meridian Bioscience Announces Closing of Transaction to Acquire Exalenz Bioscience GlobeNewswire
Apr-27-20 11:56AM	Meridian Bioscience Simplifies COVID-19 Sample Prep and Eliminates Dependence on Reagents in Short Supply GlobeNewswire +7.21%
Apr-16-20 09:00AM	Meridian Bioscience To Hold Second Quarter 2020 Financial Results Conference Call On May 8, 2020 GlobeNewswire +5.39%
Apr-15-20 12:23PM	How Should Investors Feel About Meridian Bioscience, Inc.'s (NASDAQ:VIVO) CEO Pay? Simply Wall St.
Apr-14-20 09:34AM	Meridian Bioscience offers SARS-CoV-2 antigens for COVID-19 Antibody Tests GlobeNewswire +11.70%
Apr-02-20 10:11AM	Cincinnati firms stock jumps along with sales because of coronavirus American City Business Journals +10.33%
07:30AM	MERIDIAN BIOSCIENCE ANNOUNCES BETTER-THAN-EXPECTED PRELIMINARY SECOND QUARTER FISCAL 2020 REVENUE RESULTS WITH DOUBLE-DIGIT GROWTH GlobeNewswire
Mar-16-20 11:51AM	Meridian Bioscience Supports Diagnostic Companies in Fighting Coronavirus Pandemic by Providing Zero Cost Proprietary Technology for Evaluation GlobeNewswire
08:00AM	Meridian Bioscience Announces FDA-Clearance for New Curian Analyzer and the Curian HpSA® Assay GlobeNewswire
07:15AM	Trade Alert: The President Of Meridian Bioscience, Inc. (NASDAQ:VIVO), John Kenny, Has Just Spent US$174k Buying Shares Simply Wall St.
Mar-13-20 03:27PM	How Does Meridian Bioscience's (NASDAQ:VIVO) P/E Compare To Its Industry, After The Share Price Drop? Simply Wall St. +13.64%
Mar-04-20 04:56PM	Here's how Cincinnati stocks did on Dow's 1,200-point surge American City Business Journals +7.00%
Feb-26-20 02:24PM	How Does Meridian Bioscience's (NASDAQ:VIVO) P/E Compare To Its Industry, After The Share Price Drop? Simply Wall St.
08:00AM	Meridians Novel Air-Dryable qPCR Mix Decreases Costs and Simplifies Workflows for Molecular Test Manufacturers GlobeNewswire
Feb-24-20 12:18PM	UPDATE: These Cincinnati stocks took biggest hits in Monday's selloff American City Business Journals
Feb-20-20 10:25AM	Meridian Bioscience, Inc. (NASDAQ:VIVO) Earns Among The Best Returns In Its Industry Simply Wall St.
Feb-19-20 01:16PM	One of Cincinnatis largest public companies to acquire rival for $49M American City Business Journals

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare and PediaStat brands; and urea breath testing for H. pylori under the BreathID brand. This segment also offers gastrointestinal assays, including tests for C. difficile, H. pylori, and certain foodborne pathogens; respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry assays for testing elevated levels of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. The company has a strategic collaboration with DiaSorin Inc. to sell H. pylori tests. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bihl Anthony P III	Director	Nov 25	Buy	17.65	5,000	88,266	10,851	Nov 30 10:47 AM
Baldasare Bryan T	Exec VP & CFO	Jun 30	Option Exercise	19.71	1,500	29,565	54,137	Jul 02 01:52 PM
Williams Felicia	Director	Mar 16	Buy	6.02	1,550	9,331	5,717	Mar 17 01:55 PM
Kenny John P.	Chief Executive Officer	Mar 12	Buy	5.78	30,000	173,541	238,324	Mar 13 09:05 AM
Baldasare Bryan T	Exec VP & CFO	Mar 10	Buy	6.97	2,000	13,936	52,637	Mar 11 01:47 PM
McIlwraith John	Director	Feb 25	Buy	7.59	5,000	37,950	17,167	Feb 26 09:01 AM
Rice John McCune Jr.	Director	Feb 24	Buy	7.52	3,000	22,547	12,167	Feb 26 08:51 AM
Kenny John P.	Chief Executive Officer	Feb 21	Buy	7.65	10,000	76,546	208,324	Feb 24 11:01 AM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience